Indoco Remedies, a company in the Pharmaceuticals industry, reported revenue of ₹520 crore and net profit of ₹19 crore for the September 2026 quarter.
Indoco Remedies (NSE: INDOCO) closed at ₹232.15 on 20 Nov 2026, down 7.9% over the past year. Its market capitalisation is ₹2,143 crore.
Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.